Displaying items by tag: Department of Cell, Developmental and Integrative Biology

New research from UAB shows definitive link between a protein and cell activation; shutting both down could be a target of new treatments for cancer and autoimmune diseases.

A UAB student has won a prestigious National Science Foundation grant; three UAB students received honorable mentions.

Tigatuzumab, developed at UAB with Daiichi-Sankyo, targets aggressive, hard-to-treat tumors that make up 25 percent of all breast cancers

«PrevNext»
Page 2 of 2